ENHO and metabolic dysfunction-associated steatotic liver disease: Previous studies have demonstrated a negative correlation between serum adropin levels and various diseases, highlighting the protective role of high adropin levels in conditions such as rheumatoid arthritis, diabetes, coronary atherosclerosis, and nonalcoholic fatty liver disease [28,29,30,31].